AGP Executive Report
Last update: 9 hours agoBiotech Breakthroughs: Q32 Bio reported positive 36-week topline results for bempikibart in severe alopecia areata, with no new safety signals, and plans a registration-directed path in 2027. Alzheimer’s Drug Signal: Alzheon’s Phase 3 APOLLOE4 biomarker update suggests valiltramiprosate may reduce plasma p-tau217 in APOE4/4 carriers with mild cognitive impairment. Cancer Precision Care: The Glioblastoma Foundation is building a CLIA-certified genomic testing lab to expand molecular testing access, alongside continued development of lisavanbulin. AI + Semiconductors: TSMC is adding packaging capacity in southern Taiwan, while Taiwan suppliers push toward U.S. manufacturing expansion. STEM + Education: ASML stepped up science education support in China via long-running engineering competitions. Genomics for Equity: A push for African genomics aims to build reference databases so diagnostics and trials better reflect African genetic diversity. Public Health + Policy: Massachusetts researchers warned proposed federal grant rule changes could politicize science funding. Environment + Industry: Ocean Network Canada upgraded the Baynes Sound observatory to better track acidification and low-oxygen risks for shellfish. Space Tech: NASA selected seven companies to enhance mobility on Mars.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
